Literature DB >> 30375933

Can Susceptibility-weighted MRI Help Differentiate Osteolytic from Osteoblastic Spine Metastases?

Mark E Schweitzer1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30375933     DOI： 10.1148/radiol.2018182244

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  1 in total

1.  Risk factors of skeletal-related events in patients with bone metastasis from non-small cell lung cancer undergoing treatment with zoledronate-a post hoc analysis of a randomized clinical trial.

Authors:  Hirotaka Miyashita; Christina Cruz; Cardinale Smith
Journal:  Support Care Cancer       Date:  2020-08-03       Impact factor: 3.603
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.